| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
63,599 |
53,111 |
$3.67M |
| 99199 |
Unlisted special service, procedure or report |
247,396 |
145,927 |
$1.48M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,191 |
11,808 |
$1.10M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,777 |
8,584 |
$803K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,758 |
8,523 |
$796K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
20,234 |
17,485 |
$782K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,487 |
6,465 |
$591K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,508 |
4,629 |
$478K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,930 |
5,461 |
$308K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15,752 |
13,856 |
$140K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,470 |
4,702 |
$135K |
| 96127 |
|
20,528 |
17,032 |
$107K |
| 99051 |
|
4,477 |
4,033 |
$102K |
| D0145 |
Oral evaluation for a patient under three years of age |
3,052 |
2,738 |
$101K |
| 97802 |
|
13,020 |
10,389 |
$77K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,025 |
4,411 |
$63K |
| 87899 |
|
4,623 |
4,136 |
$55K |
| D1206 |
Topical application of fluoride varnish |
3,054 |
2,739 |
$45K |
| 92551 |
|
19,138 |
16,608 |
$34K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,699 |
1,550 |
$32K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
685 |
636 |
$26K |
| 96160 |
|
6,764 |
5,598 |
$21K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,149 |
946 |
$21K |
| 95117 |
|
2,220 |
838 |
$19K |
| 85018 |
|
12,000 |
10,292 |
$17K |
| 80061 |
Lipid panel |
1,195 |
995 |
$17K |
| 96161 |
|
3,919 |
3,400 |
$13K |
| 99381 |
|
139 |
114 |
$13K |
| E0570 |
Nebulizer, with compressor |
106 |
88 |
$13K |
| 99173 |
|
19,550 |
16,979 |
$11K |
| 99401 |
|
357 |
249 |
$10K |
| 87634 |
|
363 |
288 |
$9K |
| 90686 |
|
6,298 |
5,555 |
$7K |
| 90651 |
|
327 |
291 |
$6K |
| 81003 |
|
1,925 |
1,661 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
45 |
45 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
307 |
260 |
$3K |
| 87807 |
|
223 |
187 |
$3K |
| 0072A |
|
44 |
33 |
$2K |
| 99406 |
|
467 |
451 |
$2K |
| 90734 |
|
169 |
146 |
$2K |
| 0001A |
|
38 |
27 |
$2K |
| 83718 |
|
184 |
181 |
$2K |
| 0071A |
|
45 |
27 |
$2K |
| 99177 |
|
6,313 |
5,472 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
622 |
541 |
$2K |
| 99243 |
|
13 |
13 |
$1K |
| 90619 |
|
292 |
243 |
$1K |
| 99050 |
|
41 |
34 |
$1K |
| 82465 |
|
186 |
182 |
$948.72 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
91 |
85 |
$792.83 |
| 90670 |
|
4,499 |
3,869 |
$689.53 |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
21 |
18 |
$587.95 |
| G0315 |
Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt) |
22 |
18 |
$400.01 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26 |
14 |
$281.01 |
| 90677 |
|
684 |
621 |
$268.63 |
| 36416 |
|
14,875 |
12,767 |
$227.08 |
| 96380 |
|
17 |
12 |
$205.68 |
| 90680 |
|
2,624 |
2,288 |
$200.40 |
| 90715 |
|
63 |
53 |
$44.69 |
| 90633 |
|
1,442 |
1,318 |
$32.86 |
| 99000 |
|
15,386 |
13,192 |
$20.07 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
131 |
97 |
$0.13 |
| 90723 |
|
82 |
79 |
$0.00 |
| 3074F |
|
12,161 |
9,719 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,392 |
1,943 |
$0.00 |
| 90698 |
|
1,023 |
881 |
$0.00 |
| 2001F |
|
24,056 |
18,774 |
$0.00 |
| 90656 |
|
389 |
356 |
$0.00 |
| 90744 |
|
93 |
80 |
$0.00 |
| 90647 |
|
256 |
254 |
$0.00 |
| 90697 |
|
134 |
105 |
$0.00 |
| 90696 |
|
36 |
32 |
$0.00 |
| 90716 |
|
61 |
61 |
$0.00 |
| 91307 |
|
179 |
109 |
$0.00 |
| 1160F |
|
13,874 |
10,684 |
$0.00 |
| 90648 |
|
223 |
166 |
$0.00 |
| 90707 |
|
51 |
51 |
$0.00 |
| 90380 |
|
17 |
12 |
$0.00 |
| 91300 |
|
111 |
72 |
$0.00 |
| 83655 |
|
27 |
25 |
$0.00 |
| 90700 |
|
80 |
79 |
$0.00 |
| 90710 |
|
55 |
55 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
45 |
42 |
$0.00 |
| 90685 |
|
49 |
48 |
$0.00 |
| 91308 |
|
52 |
42 |
$0.00 |
| 90661 |
|
17 |
17 |
$0.00 |